Literature DB >> 20023912

Cytotoxicity of the traditional chinese medicine (TCM) plumbagin in its copper chemistry.

Zhen-Feng Chen1, Ming-Xiong Tan, Li-Min Liu, Yan-Cheng Liu, Heng-Shan Wang, Bin Yang, Yan Peng, Hua-Gang Liu, Hong Liang, Chris Orvig.   

Abstract

The anticancer traditional Chinese medicine (TCM), plumbagin (PLN), was isolated from Plumbago Zeylanica. Reaction of plumbagin with Cu(II) salt, afforded [Cu(PLN)(2)].2H(2)O (1). With 2,2'-bipyridine (bipy) as a co-ligand, PLN reacts with Cu(II) to give [Cu(PLN)(bipy)(H(2)O)](2)(NO(3))(2).4H(2)O (2). 1 and 2 were characterized by elemental analysis, IR, ESI-MS spectra. Their crystal structures were determined by single crystal X-ray diffraction methods. The in vitro cytotoxicity of PLN, 1 and 2 against seven human tumour cell lines was assayed. The metal-based compounds exhibit enhanced cytotoxicity vs. that of free PLN, suggesting that these compounds display synergy in the combination of metal ions with PLN. The binding properties of PLN, 1 and 2 to DNA were investigated through UV-vis, fluorescence, CD spectra, and gel mobility shift assay, which indicated that 1 and 2 were non-covalent binding and mainly intercalated the neighboring base pairs of DNA. PLN, 1 and 2 exhibit inhibition activity to topoisomerase I (TOPO I), but 1 and 2 were more effective than PLN.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20023912     DOI: 10.1039/b910133k

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  10 in total

1.  Plumbagin protects against glucocorticoid-induced osteoporosis through Nrf-2 pathway.

Authors:  Shuai Zhang; Dong Li; Jing-Yan Yang; Ting-Bin Yan
Journal:  Cell Stress Chaperones       Date:  2015-05-05       Impact factor: 3.667

2.  A vanillin-based copper(ii) metal complex with a DNA-mediated apoptotic activity.

Authors:  Wendy M T Q de Medeiros; Mayara J C de Medeiros; Edinilton M Carvalho; Jailma A de Lima; Verônica da S Oliveira; Ana C F de B Pontes; Francisco O N da Silva; Javier A Ellena; Hugo A de O Rocha; Eduardo H S de Sousa; Daniel de L Pontes
Journal:  RSC Adv       Date:  2018-05-10       Impact factor: 4.036

3.  Anticancer activity, DNA binding and cell mechanistic studies of estrogen-functionalised Cu(II) complexes.

Authors:  Stephen Barrett; Michele De Franco; Andrew Kellett; Eithne Dempsey; Cristina Marzano; Andrea Erxleben; Valentina Gandin; Diego Montagner
Journal:  J Biol Inorg Chem       Date:  2019-10-26       Impact factor: 3.358

4.  Antioxidant Activities of Plumbagin and Its Cu (II) Complex.

Authors:  Mingxiong Tan; Yancheng Liu; Xujian Luo; Zhenfeng Chen; Hong Liang
Journal:  Bioinorg Chem Appl       Date:  2011-10-23       Impact factor: 7.778

Review 5.  Natural Compounds as Anticancer Agents Targeting DNA Topoisomerases.

Authors:  Chetan Kumar Jain; Hemanta Kumar Majumder; Susanta Roychoudhury
Journal:  Curr Genomics       Date:  2017-02       Impact factor: 2.236

6.  Copper (II) complexes of bidentate ligands exhibit potent anti-cancer activity regardless of platinum sensitivity status.

Authors:  Mohamed Wehbe; Cody Lo; Ada W Y Leung; Wieslawa H Dragowska; Gemma M Ryan; Marcel B Bally
Journal:  Invest New Drugs       Date:  2017-07-21       Impact factor: 3.850

7.  Design, synthesis and characterization of novel chromone based-copper(ii) antitumor agents with N,N-donor ligands: comparative DNA/RNA binding profile and cytotoxicity.

Authors:  Farukh Arjmand; Zeenat Afsan; Thierry Roisnel
Journal:  RSC Adv       Date:  2018-11-06       Impact factor: 4.036

8.  Plumbagin induces the apoptosis of human tongue carcinoma cells through the mitochondria-mediated pathway.

Authors:  Jia-xuan Qiu; Yuan-qiao He; Yong Wang; Ru-liang Xu; You Qin; Xiang Shen; Shu-Feng Zhou; Zong-fu Mao
Journal:  Med Sci Monit Basic Res       Date:  2013-08-28

9.  Cytotoxicity and apoptosis induced by a plumbagin derivative in estrogen positive MCF-7 breast cancer cells.

Authors:  Sunil Sagar; Luke Esau; Basem Moosa; Niveen M Khashab; Vladimir B Bajic; Mandeep Kaur
Journal:  Anticancer Agents Med Chem       Date:  2014-01       Impact factor: 2.505

10.  Di-copper metallodrugs promote NCI-60 chemotherapy via singlet oxygen and superoxide production with tandem TA/TA and AT/AT oligonucleotide discrimination.

Authors:  Creina Slator; Zara Molphy; Vickie McKee; Conor Long; Tom Brown; Andrew Kellett
Journal:  Nucleic Acids Res       Date:  2018-04-06       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.